Biosckin, Molecular and Cell Therapies, S.A. is a biotechnology company in the Health area whose main activity is the cell, tissue and blood-derived therapeutic products cryopreservation, but also the production of medical devices, developed in its laboratory specifically created for this purpose in 2006. From that moment on, the conditions were met to ensure levels of excellence in the processing and cryopreservation of stem cells.
Biosckin, Molecular and Cell Therapies, S.A. is a Portuguese laboratory, duly authorized by the Portuguese Authorities, the Directorate-General of Health for compliance with the regulatory requirements applicable to this activity and certified by Tüv Rheinland to comply with ISO 9001 and NP 4457 standards.
Holder of a Research, Development and Innovation (RD&I) center, called Biomat&Cell, Biosckin, Molecular and Cell Therapies, S.A. is committed to the development and research of cellular products and innovative therapeutics aimed at their use in Regenerative Medicine/Tissue Engineering, in association with the development and validation of new biomaterials and medical devices in a perspective of One Health.
At Biosckin, Molecular and Cell Therapies, S.A. there is a multidisciplinary and high qualified team of professionals with extensive experience in the field of Biotechnology, Cell-based Therapies and Bioengineering. The rigour, experience and professionalism give us the confidence of national and international brands in our laboratory.
The scientific area of Biosckin, Molecular and Cell Therapies, S.A. is led by a group of researchers and university professors, with Phd in the area of Bioengineering, Biomaterials, Biomedicine, Regenerative Medicine and Cell Therapies. Biosckin, Molecular and Cell Therapies, S.A. also has specialized and differentiated technicians, with advanced training in Clinical Analysis, Biomaterials, Bioengineering, Biotechnology, Biology, and Regulatory Affairs.
WE BELIEVE IN THE FUTURE
We believe in the potential of one of the most promising and most studied areas in the world, Regenerative Medicine.
Through the focus on research and development of new services and products we are committed to do more and better in the search for more and better solutions for all.
Our vision is in the future, in evolution, in growth. Everything for a better future.
LABORATORY 100% PORTUGUESE, AUTHORIZED AND CERTIFIED
Biosckin is a biotechnology laboratory in the area of Health in Portugal, duly authorized by the Directorate-General of Health for compliance with the regulatory requirements applicable to this activity and certified by Tüv Rheinland in compliance with ISO 9001 and NP 4457 standards.
Our mission is to develop Advanced Therapy Medicinal Products (ATMPs), mainly related with cell-based therapies, but also medical devices for application in Regenerative Medicine; to provide consultancy and services in the area of Research, Development and Innovation (RD&I) in collaboration with public and private entities of Higher Education, Research, Healthcare and Industry. Our commitment is to cooperate in Human and Technological development for a more innovative world.
Honesty and integrity in safeguarding preserved personal information and stored biological products.
Compliance with regulatory, regulatory and best practice requirements. In technical and scientific collaboration with Health Professionals, Researchers, Higher Education Professors and Technicians.
In the search for new therapeutic applications for stem cells and cell-based products and in the development of new biomaterials and medical devices.
The Biosckin, Molecular and Cell Therapies, S.A. Research, Development and Innovation Center (RD&I) allows us to focus on ongoing research in the areas of Bioengineering, Regenerative Medicine, Biomaterials, Medical Devices and Cell Therapies. Its research activity is based on a solid basis of partnerships and collaborations with national and international entities of excellence, collaborating with multidisciplinary research networks.
Business strength and creation of partnerships with scientific institutions of International reference.
Biosckin, Molecular and Cell Therapies, S.A. RD&I Nucleus builds its research on a solid basis of partnerships and collaborations with National and International entities of excellence, with a view to creating multidisciplinary research networks.
- Universidade do Porto
- Universidade do Minho
- Universidade de Lisboa
- Universidade de Coimbra
- Universidade de Trás-Os-Montes e Alto Douro
- Universidade de Lyon, França
- Universidade de Okayama, Japão
- Universidade Complutense de Madrid, Espanha
- IONISOS, França
- Celoplás – Plásticos para a Indústria S.A
- Nanologic – Tecnologias de Micro e Nanomoldação, Lda
- 3DTECH – Produção, Optimização e Reengenharia, Lda
- Stemlab, S.A.
- Instituto Nacional de Saúde Dr. Ricardo Jorge, Porto
- Instituto Pedro Nunes, Coímbra
- Banco Público de Barcelona de Sangue do Cordão (atual presidência da Netcord)
- Instituto Regea de Medicina Regenerativa da Universidade de Tâmpere, Finlândia
- Cancer Research Institute, em Londres, Inglaterra
- Instituto Salud Carlos II, Madrid
- Centro Hospitalar do Porto
- Hospital S. João
- Centro Hospitalar de Vila Nova de Gaia